ATE137965T1 - Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege - Google Patents

Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege

Info

Publication number
ATE137965T1
ATE137965T1 AT92301494T AT92301494T ATE137965T1 AT E137965 T1 ATE137965 T1 AT E137965T1 AT 92301494 T AT92301494 T AT 92301494T AT 92301494 T AT92301494 T AT 92301494T AT E137965 T1 ATE137965 T1 AT E137965T1
Authority
AT
Austria
Prior art keywords
tomoxetine
urinary tract
lower urinary
tract disorders
treat lower
Prior art date
Application number
AT92301494T
Other languages
English (en)
Inventor
Mark Mortensen Foreman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE137965T1 publication Critical patent/ATE137965T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT92301494T 1991-02-25 1992-02-24 Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege ATE137965T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66076791A 1991-02-25 1991-02-25

Publications (1)

Publication Number Publication Date
ATE137965T1 true ATE137965T1 (de) 1996-06-15

Family

ID=24650885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92301494T ATE137965T1 (de) 1991-02-25 1992-02-24 Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege

Country Status (12)

Country Link
US (1) US5441985A (de)
EP (1) EP0501705B1 (de)
JP (1) JP3222524B2 (de)
KR (1) KR920016088A (de)
AT (1) ATE137965T1 (de)
AU (1) AU642582B2 (de)
CA (1) CA2061665C (de)
DE (1) DE69210654T2 (de)
DK (1) DK0501705T3 (de)
HU (1) HU215122B (de)
PH (1) PH30083A (de)
ZA (1) ZA921292B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US6113876A (en) * 1996-01-29 2000-09-05 Eli Lilly And Company Methods of increasing sphincter competence
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
ATE305788T1 (de) * 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von inkontinenz
JP4348808B2 (ja) 1999-12-27 2009-10-21 トヨタ紡織株式会社 枠体に対する機能性部材の取付構造
JP4337201B2 (ja) 1999-12-27 2009-09-30 トヨタ紡織株式会社 スプリング構造体の取付構造
AT414238B (de) * 2001-03-06 2006-10-15 Lilly Co Eli Neues hydroxyliertes 3-phenoxy-3-phenyl-1- aminopropan und dieses aminopropan enthaltende pharmazeutische formulierung
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
US7507717B2 (en) 2002-12-02 2009-03-24 Xenome Ltd. Type II chi-conotoxin peptides (noradrenaline transporter inhibitors)
ES2383358T3 (es) 2002-12-02 2012-06-20 Xenome Ltd Péptidos de chi-conotoxina que tienen un ácido piroglutámico N-terminal
CA2519379A1 (en) * 2003-04-04 2004-10-21 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
US20060189698A1 (en) * 2005-02-24 2006-08-24 Check Jerome H Treatment of interstitial cystitis
KR101220803B1 (ko) 2010-12-28 2013-01-11 주식회사 포스코 차량용 시트 구조
DE102013019618B4 (de) * 2013-11-25 2024-08-29 Avlen Georges Tri- und Tetracyclische Verbindungen zur Behandlung von Inkontinenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GR75395B (de) * 1980-11-14 1984-07-13 Lilly Co Eli
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
IL85988A (en) * 1987-04-09 1992-08-18 Lilly Co Eli 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
SE8804003D0 (sv) * 1988-11-04 1988-11-04 Pharmacia Ab Compounds for the treatment of urinary incontinence

Also Published As

Publication number Publication date
DK0501705T3 (da) 1996-06-03
KR920016088A (ko) 1992-09-24
JP3222524B2 (ja) 2001-10-29
ZA921292B (en) 1993-08-23
US5441985A (en) 1995-08-15
AU642582B2 (en) 1993-10-21
AU1117092A (en) 1992-08-27
JPH0570343A (ja) 1993-03-23
EP0501705A1 (de) 1992-09-02
PH30083A (en) 1996-12-27
EP0501705B1 (de) 1996-05-15
CA2061665C (en) 2002-04-16
DE69210654T2 (de) 1996-10-24
HU215122B (hu) 1998-09-28
CA2061665A1 (en) 1992-08-26
DE69210654D1 (de) 1996-06-20
HU9200602D0 (en) 1992-05-28
HUT62192A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
DE69210654D1 (de) Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE69423577D1 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE69833727D1 (de) Verfahren zur Behandlung der Gefässerkrankungen mit aktiviertem Protein C
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE69800906D1 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
IT9067177A0 (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee